Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Frequent Alterations in the Expression of Serine/Threonine Kinases in Human Cancers
Maria Capra, Paolo Nucíforo, Stefano Confalonieri, et al.
Cancer Research (2006) Vol. 66, Iss. 16, pp. 8147-8154
Open Access | Times Cited: 192

Showing 26-50 of 192 citing articles:

Enhanced Cardiac Regenerative Ability of Stem Cells After Ischemia-Reperfusion Injury
Darukeshwara Joladarashi, Venkata Naga Srikanth Garikipati, Rajarajan A. Thandavarayan, et al.
Journal of the American College of Cardiology (2015) Vol. 66, Iss. 20, pp. 2214-2226
Open Access | Times Cited: 68
Discovery and in silico evaluation of aminoarylbenzosuberene molecules as novel checkpoint kinase 1 inhibitor determinants
Rahul Singh, Vijay Kumar Bhardwaj, Jatin Sharma, et al.
Genomics (2020) Vol. 113, Iss. 1, pp. 707-715
Open Access | Times Cited: 67
Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response–Targeted Therapies in Breast Cancer
Kalnisha Naidoo, Patty T. Wai, Sarah Maguire, et al.
Molecular Cancer Therapeutics (2018) Vol. 17, Iss. 1, pp. 306-315
Open Access | Times Cited: 62
Exosomes from M1‐polarized macrophages promote apoptosis in lung adenocarcinoma via the miR‐181a‐5p/ETS1/STK16 axis
Xuan Wang, Renhong Huang, Zhouyi Lu, et al.
Cancer Science (2022) Vol. 113, Iss. 3, pp. 986-1001
Open Access | Times Cited: 33
CDK12 promotes tumorigenesis but induces vulnerability to therapies inhibiting folate one-carbon metabolism in breast cancer
Maria Grazia Filippone, Daniela Gaglio, R. Bonfanti, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 31
Nek7 kinase targeting leads to early mortality, cytokinesis disturbance and polyploidy
Hagit Salem, Inbal Rachmin, Nissan Yissachar, et al.
Oncogene (2010) Vol. 29, Iss. 28, pp. 4046-4057
Open Access | Times Cited: 80
Nek6 Mediates Human Cancer Cell Transformation and Is a Potential Cancer Therapeutic Target
Rounak Nassirpour, Lihua Shao, Peter M. Flanagan, et al.
Molecular Cancer Research (2010) Vol. 8, Iss. 5, pp. 717-728
Closed Access | Times Cited: 75
The histone methyltransferase Wolf–Hirschhorn syndrome candidate 1‐like 1 (WHSC1L1) is involved in human carcinogenesis
Daechun Kang, Hyun‐Soo Cho, Gouji Toyokawa, et al.
Genes Chromosomes and Cancer (2012) Vol. 52, Iss. 2, pp. 126-139
Closed Access | Times Cited: 73
“Stop Ne(c)king around”: How interactomics contributes to functionally characterize Nek family kinases
Gabriela Vaz Meirelles, Arina Marina Perez, Edmárcia Elisa de Souza, et al.
World Journal of Biological Chemistry (2014) Vol. 5, Iss. 2, pp. 141-160
Open Access | Times Cited: 64
Novel thiazole derivatives: a patent review (2008 – 2012. Part 2)
Alberto Leoni, Alessandra Locatelli, Rita Morigi, et al.
Expert Opinion on Therapeutic Patents (2014) Vol. 24, Iss. 7, pp. 759-777
Closed Access | Times Cited: 57
SI113, a Specific Inhibitor of the Sgk1 Kinase Activity that Counteracts Cancer Cell Proliferation
Lucia D’Antona, Rosario Amato, Cristina Talarico, et al.
Cellular Physiology and Biochemistry (2015) Vol. 35, Iss. 5, pp. 2006-2018
Open Access | Times Cited: 54
Nek7 Protects Telomeres from Oxidative DNA Damage by Phosphorylation and Stabilization of TRF1
Rong Tan, Satoshi Nakajima, Qun Wang, et al.
Molecular Cell (2017) Vol. 65, Iss. 5, pp. 818-831.e5
Open Access | Times Cited: 52
Design, synthesis and biological evaluation of certain CDK2 inhibitors based on pyrazole and pyrazolo[1,5-a] pyrimidine scaffold with apoptotic activity
Ghada Ali, Diaa A. Ibrahim, Amira M. Elmetwali, et al.
Bioorganic Chemistry (2019) Vol. 86, pp. 1-14
Closed Access | Times Cited: 52
Medicinal attributes of pyrazolo[1,5-a]pyrimidine based scaffold derivatives targeting kinases as anticancer agents
Nasser S. M. Ismail, Ghada Ali, Diaa A. Ibrahim, et al.
Future Journal of Pharmaceutical Sciences (2016) Vol. 2, Iss. 2, pp. 60-70
Open Access | Times Cited: 47
The Diverse Roles of TAO Kinases in Health and Diseases
Chih‐Yeu Fang, Tsung‐Ching Lai, Michael Hsiao, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7463-7463
Open Access | Times Cited: 47
Expression of the NEK family in normal and cancer tissue: an immunohistochemical study
Talita Diniz Melo‐Hanchuk, Mariana Bonjiorno Martins, Lucas Leite Cunha, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 39
Synthesis, cytotoxicity of some pyrazoles and pyrazolo[1,5-a]pyrimidines bearing benzothiazole moiety and investigation of their mechanism of action
Ebtehal M. Husseiny
Bioorganic Chemistry (2020) Vol. 102, pp. 104053-104053
Closed Access | Times Cited: 39
Inhibition of NEK7 Suppressed Hepatocellular Carcinoma Progression by Mediating Cancer Cell Pyroptosis
Zilong Yan, Qingen Da, Zhangfu Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 24
Proteomic characterization of post-translational modifications in drug discovery
Linhui Zhai, Kai‐Feng Chen, Bingbing Hao, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 12, pp. 3112-3129
Open Access | Times Cited: 23
Multi-Omics Analysis Revealed That TAOK1 Can Be Used as a Prognostic Marker and Target in a Variety of Tumors, Especially in Cervical Cancer
Ning Li, Xiu Li, Yating Xu, et al.
OncoTargets and Therapy (2025) Vol. Volume 18, pp. 335-353
Open Access
A Kinetic Test Characterizes Kinase Intramolecular and Intermolecular Autophosphorylation Mechanisms
Charlotte A. Dodson, Sharon Yeoh, Tamanna Haq, et al.
Science Signaling (2013) Vol. 6, Iss. 282
Closed Access | Times Cited: 52
Hsp72 is targeted to the mitotic spindle by Nek6 to promote K-fiber assembly and mitotic progression
Laura O’Regan, Josephina Sampson, Mark W. Richards, et al.
The Journal of Cell Biology (2015) Vol. 209, Iss. 3, pp. 349-358
Open Access | Times Cited: 49
Development of Selective Clk1 and -4 Inhibitors for Cellular Depletion of Cancer-Relevant Proteins
Ahmed K. ElHady, Mohammad Abdel‐Halim, Alireza Abadi, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 13, pp. 5377-5391
Closed Access | Times Cited: 46
Altered serine/threonine kinase activity in schizophrenia
Jennifer L. McGuire, John H. Hammond, Stefani D. Yates, et al.
Brain Research (2014) Vol. 1568, pp. 42-54
Open Access | Times Cited: 45
Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myeloma
Mariateresa Fulciniti, Joaquín Martínez‐López, William Senapedis, et al.
Blood (2017) Vol. 129, Iss. 16, pp. 2233-2245
Open Access | Times Cited: 45

Scroll to top